Literature DB >> 32268090

TBK1 and IKKε Act Redundantly to Mediate STING-Induced NF-κB Responses in Myeloid Cells.

Katherine R Balka1, Cynthia Louis2, Tahnee L Saunders3, Amber M Smith4, Dale J Calleja2, Damian B D'Silva2, Fiona Moghaddas2, Maximilien Tailler3, Kate E Lawlor5, Yifan Zhan6, Christopher J Burns7, Ian P Wicks8, Jonathan J Miner4, Benjamin T Kile9, Seth L Masters2, Dominic De Nardo10.   

Abstract

Stimulator of Interferon Genes (STING) is a critical component of host innate immune defense but can contribute to chronic autoimmune or autoinflammatory disease. Once activated, the cyclic guanosine monophosphate (GMP)-adenosine monophosphate (AMP) (cGAMP) synthase (cGAS)-STING pathway induces both type I interferon (IFN) expression and nuclear factor-κB (NF-κB)-mediated cytokine production. Currently, these two signaling arms are thought to be mediated by a single upstream kinase, TANK-binding kinase 1 (TBK1). Here, using genetic and pharmacological approaches, we show that TBK1 alone is dispensable for STING-induced NF-κB responses in human and mouse immune cells, as well as in vivo. We further demonstrate that TBK1 acts redundantly with IκB kinase ε (IKKε) to drive NF-κB upon STING activation. Interestingly, we show that activation of IFN regulatory factor 3 (IRF3) is highly dependent on TBK1 kinase activity, whereas NF-κB is significantly less sensitive to TBK1/IKKε kinase inhibition. Our work redefines signaling events downstream of cGAS-STING. Our findings further suggest that cGAS-STING will need to be targeted directly to effectively ameliorate the inflammation underpinning disorders associated with STING hyperactivity.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IKKε; NF-κB; STING; TBK1; cGAS; cytokines; innate immunity; protein kinases; signal transduction; type I interferons

Mesh:

Substances:

Year:  2020        PMID: 32268090     DOI: 10.1016/j.celrep.2020.03.056

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  64 in total

Review 1.  Crosstalk between cGAS-STING signaling and cell death.

Authors:  Ambika M V Murthy; Nirmal Robinson; Sharad Kumar
Journal:  Cell Death Differ       Date:  2020-09-18       Impact factor: 15.828

2.  A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatment.

Authors:  Marino Nagata; Akemi Kosaka; Yuki Yajima; Syunsuke Yasuda; Mizuho Ohara; Kenzo Ohara; Shohei Harabuchi; Ryusuke Hayashi; Hiroshi Funakoshi; Jun Ueda; Takumi Kumai; Toshihiro Nagato; Kensuke Oikawa; Yasuaki Harabuchi; Celis Esteban; Takayuki Ohkuri; Hiroya Kobayashi
Journal:  Cancer Immunol Immunother       Date:  2021-01-28       Impact factor: 6.968

3.  dsDNA-induced AIM2 pyroptosis halts aberrant inflammation during rhabdomyolysis-induced acute kidney injury.

Authors:  Chintogtokh Baatarjav; Takanori Komada; Tadayoshi Karasawa; Naoya Yamada; Ariunaa Sampilvanjil; Takayoshi Matsumura; Masafumi Takahashi
Journal:  Cell Death Differ       Date:  2022-06-23       Impact factor: 15.828

Review 4.  No Longer A One-Trick Pony: STING Signaling Activity Beyond Interferon.

Authors:  Jianjun Wu; Nan Yan
Journal:  J Mol Biol       Date:  2021-10-08       Impact factor: 5.469

Review 5.  Glial TDP-43 and TDP-43 induced glial pathology, focus on neurodegenerative proteinopathy syndromes.

Authors:  Katherine E Prater; Caitlin S Latimer; Suman Jayadev
Journal:  Glia       Date:  2021-09-24       Impact factor: 7.452

6.  DNA Repair Inhibition Leads to Active Export of Repetitive Sequences to the Cytoplasm Triggering an Inflammatory Response.

Authors:  Xuan Song; Jacqueline T M Aw; Fulin Ma; Ming Fung Cheung; Danny Leung; Karl Herrup
Journal:  J Neurosci       Date:  2021-09-30       Impact factor: 6.167

7.  TBK1-medicated DRP1 phosphorylation orchestrates mitochondrial dynamics and autophagy activation in osteoarthritis.

Authors:  Sun-Li Hu; Abdullah Al Mamun; Jian Shaw; Sun-Long Li; Yi-Feng Shi; Xue-Man Jin; Ying-Xin Yu; Chao-Zhi Pang; Ze-Yang Li; Jia-Jie Lu; Yue-Piao Cai; Xiang-Yang Wang; Jian Xiao
Journal:  Acta Pharmacol Sin       Date:  2022-08-25       Impact factor: 7.169

Review 8.  Targeting TANK-binding kinase 1 (TBK1) in cancer.

Authors:  Or-Yam Revach; Shuming Liu; Russell W Jenkins
Journal:  Expert Opin Ther Targets       Date:  2020-10-05       Impact factor: 6.902

Review 9.  Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy.

Authors:  Kyle M Garland; Taylor L Sheehy; John T Wilson
Journal:  Chem Rev       Date:  2022-02-02       Impact factor: 60.622

Review 10.  Autophagy in inflammation, infection, and immunometabolism.

Authors:  Vojo Deretic
Journal:  Immunity       Date:  2021-03-09       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.